Inhibition of neonatal hyperbilirubinemia in breast fed infants

Details Inhibition of neonatal hyperbilirubinemia in breast fed infants Inhibition of neonatal hyperbilirubinemia in breast fed infants

A - Human Necessities

61

K

A61K 38/17 (2006.01) A23C 9/20 (2006.01) A23L 1/29 (2006.01) A23L 1/305 (2006.01)

Patent

CA 2461560

Disclosed herein are infant supplements containing casein, a salt of casein, whey and/or a casein hydrolysate which are free of carbohydrate, and methods for their use with breast feeding babies. The supplements are designed to suppress serum bilirubin levels and the incidence and severity of neonate jaundice. In one form, a dose of such a supplement is mixed with human breast milk and fed to the neonate.

L'invention concerne des compléments alimentaires infantiles contenant de la caséine, un sel de caséine, du lactosérum et/ou un hydrolysat de caséine, sans hydrate de carbone, ainsi que des méthodes d'utilisation de ces compléments avec des nourrissons. Ces compléments sont conçus afin de supprimer les taux sériques de bilirubine ainsi que l'incidence et la sévérité de la jaunisse néonatale. Selon un mode de réalisation de l'invention, une dose d'un tel complément est mélangée au lait humain et l'ensemble est donné au nourrisson.

Affiliated with

Also associated with

Rating

Inhibition of neonatal hyperbilirubinemia in breast fed infants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of neonatal hyperbilirubinemia in breast fed infants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of neonatal hyperbilirubinemia in breast fed infants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1642448